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Hepatitis B virus (HBV) synthesizes itsDNAgenome through reverse transcription,which is catalyzed by viral polymerase (Pol). Pre-
vious studies suggested that theRNaseHdomain of hepadnaviral Polmay contribute tomultiple steps of the viral genome replication,
such as RNAencapsidation and viralDNA synthesis.However, specific residues of theRNaseHdomain that contribute to viral reverse
transcription have not been determined. Therefore, we employed charged-to-alanine scanningmutagenesis to generate a set of single-
substitutionmutants of theRNaseHdomain and then analyzed their ability to support viral reverse transcription. Southern blot anal-
ysis showed that threemutants (R703A,D777A, andR781Amutants) yielded significantly reduced amounts of viralDNAs.However,
none of thesemutantswere defective inRNAencapsidation. The data indicated that in theR703A andD777Amutants,minus-strand
DNA synthesiswas incomplete due to loss of catalytic activity of RNaseH. In contrast, in theR781Amutant, theminus-strandDNA
synthesiswas near complete to some extent, while the plus-strandDNA synthesis (i.e., relaxed circularDNA)was severely impaired
due to the defect inRNaseHactivity.Overall, our analysis revealed that three charged residues of theHBVPol RNaseHdomain con-
tribute to the catalysis of RNaseH in removing theRNA template, but not in theRNAencapsidation.
Hepatitis B virus (HBV), the prototypic member of the hepad-navirus family, is a major cause of liver disease worldwide,
ranging from acute and chronic hepatitis to liver cirrhosis and
hepatocellular carcinoma. Other members of the hepadnavirus
family include woodchuck hepatitis virus (WHV) and duck hep-
atitis B virus (DHBV) (1). The DNA genome of hepadnaviruses is
replicated through reverse transcription, which takes place within
the viral capsid in the cytoplasm of infected cells (Fig. 1). Recog-
nition of a stem-loop structure (an encapsidation signal desig-
nated ε near the 5= end of the pregenomic RNA [pgRNA]) by viral
polymerase (Pol) directs encapsidation of the pgRNA and Pol into
a nascent capsid particle (2–4). Minus-strand DNA synthesis is
initiated by protein priming using Pol as a primer and the bulge
region of ε as a template (5, 6). Following synthesis of three or four
nucleotides, the nascent minus-strand DNA switches templates to
a position near the 3= end of the pgRNA, i.e., the 3= copy of direct
repeat 1 (DR1*) (Fig. 1A). The minus-strand DNA synthesis then
resumes, with the RNase H activity of the Pol degrading the
pgRNA, proceeding to the 5=end of the pgRNA, and resulting in a
full-length minus-strand DNA (Fig. 1B and C).
A short segment of RNA, the remnant of the pgRNA cleavage
by RNase H activity, serves as an RNA primer for plus-strand
DNA synthesis (7). Depending on whether or not the second tem-
plate switch takes place during plus-strand DNA synthesis, one of
two distinct double-strand DNA products—relaxed circular (RC)
DNA or duplex linear (DL) DNA—is generated (Fig. 1E and F).
The RC DNA is generated when the RNA primer translocates to
DR2, termed primer translocation, near the 5= end of the minus-
strand DNA template (Fig. 1D). Following translocation, the plus-
strand DNA synthesis initiated from DR2 proceeds to the 5= end of
the minus-strand template (8). For continuation of plus-strand
DNA synthesis, an intramolecular template switch must occur
(Fig. 1E). The third template switch, termed circularization, re-
sults in a relaxed circular conformation of the genome. In con-
trast, the DL DNA is generated when plus-strand DNA synthesis is
initiated at DR1 without primer translocation, termed in situ
priming (Fig. 1F).
In fact, reverse transcriptases (RTs) exhibit RNase H activity as
well as RNA- and DNA-directed DNA polymerase activities (9).
Unlike those of its retroviral counterpart, far less is known about
the functional role of the RNase H domain in hepadnaviral Pol.
Previous studies with DHBV suggested that the RNase H domain
of DHBV Pol may contribute to multiple steps of viral genome
replication, such as RNA encapsidation and minus-strand DNA
synthesis (10, 11). The requirement of the RNase H domain in
RNA packaging was demonstrated by analysis of deletion or sub-
stitution mutations in the DHBV RNase H domain. Regarding
minus-strand DNA synthesis, substitution mutations of the puta-
tive catalytic residues in the RNase H domain affected removal of
the RNA strand of RNA-DNA hybrids, synthesis of viral plus-
strand DNA, and DNA polymerase activity (12).
The so-called “clustered charged-to-alanine (CA)” mutagene-
sis method has been successfully used to examine the contribution
of charged amino acid residues to a specific function of the protein
of interest (13). Specifically, the method is to replace two charged
amino acids (i.e., arginine, lysine, aspartic acid, and glutamic acid)
located within a sequence of, at most, five amino acids with ala-
nine. Clusters of charged amino acids, typically located on the
surface of proteins, likely participate in the molecular recognition
process, while substitution with alanine would cause only a local
alteration, if any, in an otherwise native polypeptide (14). Previ-
ously, we employed extensive CA mutagenesis to gain further in-
sight into the contribution of the terminal protein (TP) domain of
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HBV Pol to viral reverse transcription, and we uncovered that a
charged amino acid (i.e., Arg105) is critical for RNA encapsida-
tion (15).
In this study, we employed CA mutagenesis to determine the
role of charged residues of the HBV Pol RNase H domain. Of the
16 charged residues we examined, three single-substitution mu-
tants yielded significantly reduced levels of viral DNA, suggesting
a role for these charged residues in viral DNA synthesis. The data
showed that two mutants (R703A and D777A mutants) failed to
synthesize the viral DNA due to loss of the catalytic activity of the
RNase H domain, whereas the R781A mutant normally synthe-
sized single-stranded (SS) DNA and DL DNA but failed to synthe-
size RC DNA. The lack of RC DNA synthesis is perhaps due to a
failure in generating the appropriate RNA primer essential for RC
DNA synthesis due to a defect in RNase H activity. Overall, the
minus-strand DNA synthesis appeared to be linked to RNase H
activity in the R703A and D777A mutants but not in the R781A
mutant.
MATERIALS AND METHODS
Cell culture and transfection. HepG2 (ATCC; HB-8065) cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% (vol/vol) fetal bovine serum and antibiotic-antimycotic solu-
tion (Invitrogen) at 37°C in 5% CO2. Transfection via polyethylenimine
(PEI) (linear; 25 kDa; Polysciences, Inc.) was performed as previously
described (16), except for the following modifications. Cells were seeded
at a confluence of 40 to 50%. The ratio of DNA to PEI was kept at 1:2
(g/g), and DNA and PEI were mixed in 150 mM NaCl at room tem-
perature for 10 min. DNA-PEI complex solution was directly added to the
medium. After 24 h, cells were fed with fresh medium and were harvested
4 days posttransfection.
Plasmid construction. The nucleotide sequences of the HBV genome
were numbered starting at the unique EcoRI site of the HBV ayw subtype
(GenBank accession number V01460) (17). In this numbering system, nucle-
otide position 1 of HBV ayw subtype is the A of the EcoRI site (GAATTC).
Details of HBV P-null replicon and pCMV-Pol constructs were previously
described (15). Briefly, the HBV p-null construct, which expresses HBV
pgRNA under the control of its own promoter and all the other proteins
except for HBV polymerase, is made by introducing two mutations into the P
open reading frame (ORF). The pCMV-Pol is an HBV polymerase expressing
plasmid with three copies of the FLAG tag at its N terminus. All substitution
mutants were generated by overlap extension PCR protocol, as previously
described (18), and confirmed by DNA sequencing.
Isolation of viral DNAs. Viral DNAs from cytoplasmic capsids were
isolated from HepG2 cells after transfection (19). Cells were lysed in 0.5
FIG 1 Reverse transcription of the HBV genome. The pgRNA (dashed line) serves as a template for minus-strand DNA synthesis and contains 11-nt direct
repeats (DR1 and DR2; open boxes) and epsilon stem-loop structures (ε). The oval represents HBV Pol protein. (A) The Pol protein initiates reverse transcription
from the 5= ε. The newly synthesized nascent minus-strand DNA (thick gray line) switches template to the 3= copy of DR1. (B) Following the minus-strand
template switch, the minus-strand DNA is extended, while RNase H activity of the Pol protein degrades the pgRNA. (C) A small RNA segment, which contains
DR1, resulting from the RNase H activity of the Pol protein, is used as an RNA primer for plus-strand DNA synthesis. (D) The RNA primer then switches template
from DR1 to DR2 and resumes the plus-strand DNA synthesis (thick black line). (E) To generate the mature RC DNA, growing plus-strand DNA switches
templates from the 5= end to the 3= end of the minus-strand DNA. (F) Alternatively, the plus-strand DNA synthesis (i.e., in situpriming) initiates at DR1, resulting
in DL DNA.
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ml of 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, and 1%
NP-40 for 10 min and were clarified by centrifugation to pellet debris and
nuclei. For the detection of HBV Pol and its substitution mutants, 3%
(vol/vol) fraction of lysates were taken after centrifugation and then ana-
lyzed by immunoblotting. The clarified cell lysates were adjusted to 10
mM MgCl2, 100 g/ml of DNase I (Sigma), and 100 g/ml of RNase A
(Sigma) and incubated at 37°C to remove the transfected plasmid DNAs
and unencapsidated HBV RNAs. After incubation for 3 h, the cell
lysates were centrifuged, and cytoplasmic capsids were precipitated
with polyethylene glycol (PEG 8000; USB). Precipitated capsids were
resuspended in 10 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 1 mM
EDTA and digested with proteinase K (Sigma) to 240 g/ml and SDS to
0.5% for 3 h. Viral DNAs were purified by phenol-chloroform extraction,
precipitated with ethanol, and rehydrated for analysis of primer extension
and Southern blotting. For primer extension analysis, viral DNAs were
subsequently hydrolyzed by alkali treatment, neutralized, and precipi-
tated with ethanol as described elsewhere (8). For Southern blot analysis,
the alkaline hydrolysis procedure was omitted.
Southern blot analysis.Viral DNAs from cytoplamic capsids of trans-
fected HepG2 cells were analyzed by Southern blotting to measure viral
replication intermediates, as described previously (20). In brief, viral
DNAs isolated from a 35-mm plate were electrophoresed through a 1.3%
agarose gel, transferred onto a nylon membrane, and subjected to UV
cross-linking. The membrane was prehybridized and then hybridized
with an [-32P]dCTP-labeled HBV-specific probe for 12 h at 65°C. The
membrane was washed and autoradiographed on an imaging plate. Images
were obtained using a phosphorimager scanner (BAS-2500; Fujifilm). For
Fig. 6C, viral DNAs isolated from a 100-mm plate were heat denatured at
95°C for 5 min and immediately cooled on ice before electrophoresis. The
1820-F primer (complementary to nucleotides [nt] 1820 to 1836), which
binds to 3= end of the minus-strand DNA, was 5= end labeled with [-
32P]ATP (21). The membrane blot was incubated with the full-length
minus DNA-specific probe for 12 h at 42°C to facilitate annealing of the
oligonucleotide probe to HBV DNAs on the membrane. For Fig. 7, viral
DNAs were divided into two equal aliquots; one was left untreated, and
the other was treated with Escherichia coli RNase H (New England Bio-
Labs) at 37°C for 20 min before electrophoresis to determine whether
pgRNA remains undegraded during the process of minus-strand elonga-
tion.
Primer extension analysis. Viral DNAs isolated from a 60-mm plate
by the above-mentioned methods were divided into five equal aliquots.
One aliquot of the sample was used together with the 1665-F primer
(complementary to nt 1665 to 1689) to determine the amount of minus-
strand DNA initiated at the 3= copy of DR1 and extended. Two other
aliquots of the sample were used together with the 1774-R primer (com-
plementary to nt 1744 to 1722) to measure the level of plus-strand DNA
initiated at DR2 before the circularization step. The other two aliquots of
the sample were used together with the 1952-R primer (complementary to
nt 1952 to 1930) to determine the amount of plus-strand DNA initiated at
DR2 and circularized. All primers were 5= end labeled using [-32P]ATP
and polynucleotide kinase (New England BioLabs). Primer extension re-
action was performed with Deep VentR (exo-) DNA polymerase (New
England BioLabs) (20), and 100 to 200 pg of internal standard DNAs was
added to each sample prior to the extension. The thermal cycler setting
used for the extension with all three primers was 20 cycles of 95°C for 30 s,
53°C for 40 s, and 72°C for 30 s. Primer extension products were then
denatured at 95°C for 5 min prior to electrophoresis through 6% poly-
acrylamide-7 M urea gels. The gel was dried, and autoradiography was
conducted as mentioned for Southern blot analysis. The sizes of extended
products were 165 nt for the 1665-F primer, 142 nt for the 1744-R primer,
and 350 nt for the 1952-R primer. A sequencing ladder was generated
using Sequenase, version 2.0, DNA sequencing kit (Affymetrix).
Western blot analysis. Protein samples obtained from the above-
mentioned cell lysis procedure were resolved by SDS-10% polyacrylamide
gel electrophoresis (PAGE) and transferred to a polyvinylidene difluoride
(PVDF) membrane (Bio-Rad). After being blocked, the membrane was
incubated with a mouse anti-FLAG M2 antibody (diluted 1:5,000; Sigma)
to detect FLAG-tagged HBV polymerases. -Actin was detected using a
rabbit anti-actin antibody (diluted 1:5,000; Sigma). Proteins were visual-
ized by an ECL detection system (AbFrontier, Republic of Korea). Images
were quantified using LAS-4000 (Fujifilm).
RNA extraction and RPA. RNAs from whole cells and cytoplasmic
capsids were isolated 3 days after transfection using acid guanidinium
thiocyanate-phenol-chloroform extraction (22, 23). Approximately twice
more RNA of the capsid fraction (C), compared with total cytoplasmic
fraction (T), was subjected to RNase protection analysis (RPA), according
to the manufacturer’s procedure (Ambion). Specifically, a riboprobe used
to detect HBV-specific RNAs was generated by the in vitro transcription of
the core region (complementary to nt 1903 to 2139). Each sample of RNA
was hybridized with the [-32P]UTP-labeled probe for 16 h at 42°C.
RNase digestion was carried out with a mixture of RNase A and RNase T1
for 50 min at 37°C. The digested products were separated on 6% acryl-
amide-7 M urea gels. Images were obtained using a phosphorimager
(BAS-2500; Fujifilm).
RESULTS
SomeCAmutants in theHBVRNaseHdomain fail to synthesize
viral DNA. To explore the role of the RNase H domain in reverse
transcription, we introduced CA mutagenesis in the RNase H do-
main of HBV Pol as described in Materials and Methods. Six CA
mutants were first generated as shown in Fig. 2. Three single point
mutants harboring an alanine substitution in the putative catalytic
site (D689, E718, and D737) were also generated in parallel. We
examined the ability of each mutant to support viral DNA synthe-
sis via complementation procedure, as previously described (24).
HepG2 cells were transfected with an individual CA mutant along
with a HBV P-null replicon construct harboring a frameshift mu-
tation in the P ORF that otherwise yields mature viral DNAs.
Southern blot analysis of cytoplasmic core DNA showed that the
wild-type (WT) Pol yielded three species of viral replication inter-
mediates: RC, DL, and SS DNAs (Fig. 3A, lane 1). HBV Pol derived
from two mutants—CA2 and CA6 —supported WT levels of viral
genome replication, suggesting that the amino acid residues mu-
tated in CA2 and CA6 were not essential for viral genome replica-
tion (Fig. 3A, lanes 3 and 7). In contrast, HBV Pol derived from
FIG 2 Schematic illustrating HBV Pol-expression plasmids used in this study.
HBV Pol consists of four different subdomains: the terminal protein (TP),
spacer, RT, and the RNase H domain. The positions of the clustered CA mu-
tants in the HBV RNase H domain are indicated. The positions of alanine
substitutions at the putative catalytic sites (D689, E718, and D737) are denoted
as well. The amino acid number of each subdomain and three copies of the
FLAG epitopes at its N terminus are labeled.
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another two CA mutants—CA1 and CA4 —yielded a barely de-
tectable amount of viral DNAs, suggesting a role for the residues
mutated in CA1 and CA4 in viral genome replication (Fig. 3A,
lanes 2 and 5). Intriguingly, the remaining two mutants—CA3
and CA5—led to synthesis of reduced amounts of DL and SS
DNAs but failed to produce a detectable level of RC DNA (Fig. 3A,
lanes 4 and 6). Comparable expression of HBV Pol protein was
measured by Western blot analysis (Fig. 3B), confirming that the
barely detectable levels of viral DNAs in the CA1 and CA4 mutants
were not due to a lack of Pol protein expression. A similar obser-
vation was made in Huh7 cells (data not shown). As expected,
significantly reduced amount of viral DNAs were detectable in the
putative catalytic-site mutants (Fig. 3C). Overall, the eight
charged residues altered in the four CA mutants (CA1, CA3, CA4,
and CA5) were subjected to further analysis.
A single substitution reveals charged residues that are criti-
cal for viral DNA synthesis. To determine the specific residue
responsible for viral DNA synthesis of the two altered residues in
the four CA mutants mentioned above, eight single-substitution
mutants were generated. Each mutant DNA was transfected and
then analyzed by Southern blotting as shown in Fig. 4A. In CA1,
the R703A mutant was severely defective in viral DNA synthesis,
while the R705A mutant was normal in viral DNA synthesis (Fig.
4A, lanes 2 and 3), suggesting that R703A fully accounts for the
defect seen in CA1. Notably, a few bands migrating faster than DL
or SS DNA were detectable in R703A mutant-transfected cells,
mirroring those detected in the putative catalytic-site mutants
(Fig. 3C). In CA3, the K745A mutant led to modestly reduced
synthesis of the RC and SS DNAs, while the R744A mutant led to
near-WT levels of viral DNA synthesis (Fig. 4A, lanes 4 and 5).
Thus, the defect of the K745A mutant appears to fully account for
the defect seen in CA3. Notably, the DL DNA synthesis proceeded
normally, while the RC DNA synthesis was impaired in the K745A
mutant. In CA4, the D777A mutant appeared severely defective in
viral DNA synthesis, yielding a few fast-migrating bands (Fig. 4A,
lane 6) similar in size and pattern to those seen with the putative
catalytic-site mutants (Fig. 3C). In contrast, the D778A mutant led
to modestly reduced synthesis of all three viral replication inter-
mediates (Fig. 4A, lane 7). Therefore, the defect seen in CA4
seemed to be primarily attributable to the defect in the D777A
mutant and, to a lesser extent, in the D778A mutants. In CA5, the
R781A mutant led to significantly reduced synthesis of the RC
DNA, while R783A led to near-WT-level synthesis of viral DNAs
(Fig. 4A, lanes 8 and 9). Thus, R781A substitution appears to be
fully responsible for the defect seen in CA5. Overall, the data show
that five single-substitution mutants (R703A, K745A, D777A,
D778A, and R781A mutants) were defective in yielding WT levels
of viral DNAs (Fig. 4A). Comparable expression of HBV Pol pro-
tein was confirmed by Western blot analysis (Fig. 4B).
None of the charged residues are essential for RNA encapsi-
dation. To determine the step at which the above-mentioned sin-
gle-site mutants are defective, we next examined RNA encapsida-
tion, a step prior to viral reverse transcription. Cells were
transfected, and then viral pgRNA was extracted from both cap-
FIG 3 Analysis of CA mutants for the ability to support viral genome replica-
tion. (A) Cells were cotransfected with a HBV P-null replicon construct along
with WT Pol or individual CA mutant constructs as indicated. Intracellular
capsid-associated DNAs were isolated and analyzed by Southern blotting. The
viral replication intermediates, RC, DL, and SS DNAs, are denoted. A restric-
tion fragment representing one HBV genomic unit (3.2 kb) serves as a size
marker (SM) (open arrowhead). The experiment was repeated four times, and
representative data are shown. (B) Cytoplasmic lysates, equivalent to 3% input
from the same cells transfected with the constructs indicated, were analyzed by
immunoblotting. The levels of HBV Pol and -actin were measured using
anti-Flag and anti-actin antibodies, respectively. (C) Intracellular capsid-asso-
ciated DNAs obtained from three catalytic-site mutants were isolated and an-
alyzed similarly to the assay described above.
FIG 4 Three charged residues in the RNase H domain are critical for RC DNA
synthesis. (A) Cells were cotransfected with an HBV P-null replicon construct
along with WT Pol or an individual single substitution mutant as indicated.
Southern blot analysis was performed to detect the three replication interme-
diates: RC, DL, and SS DNAs. Asterisks to the right of the labeled bands denote
replication intermediates that appear in only two individual mutants (R703A
and D777A). The experiment was repeated six times, and representative data
are shown. (B) The expression of HBV Pols was evaluated by immunoblotting
from cytoplasmic lysates (input: 3%) obtained from the same cells as trans-
fected for panel A. -Actin served as a loading control.
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sids (C) and total cells (T) and analyzed by RNase protection
analysis (RPA) as detailed in Materials and Methods. As shown in
Fig. 5, none of the mutants appeared defective in RNA encapsida-
tion, indicating that none of these charged residues are essential
for RNA encapsidation. This finding led us to examine the viral
reverse transcription.
Some mutants have a defect in minus-strand elongation. To
further narrow down the defect of the above-described five mu-
tants in viral DNA synthesis, we next investigated whether the
minus-strand DNA was normally synthesized. Primer extension
analysis was performed as previously described (21), and the strat-
egy is shown in Fig. 6A. We carried out primer extension analysis
using the 1665-F primer to measure the amount of minus-strand
DNA initiated at the 3= copy of DR1 (Fig. 6A). The extended
products from the minus-strand DNA initiated at DR1 were de-
tected in cells transfected with a WT Pol (Fig. 6B, lane 1). In con-
trast, modestly reduced levels of minus-strand DNAs that were
initiated at DR1 were detected in all five mutants (Fig. 6B, lanes 2
to 6). One interpretation of these results is that none of these
charged residues are critically important for minus-strand DNA
synthesis at DR1.
Though the above-mentioned mutants appeared not to be de-
fective in initiation of minus-strand DNA, they nonetheless failed
to accumulate RC DNA to WT levels. Thus, we next examined
whether or not minus-strand DNA synthesis was completed by
probing the very end of the minus-strand DNA with the 1820-F
oligomer (Fig. 6A) following heat denaturation of viral DNAs, as
previously described (21). Unexpectedly, both DL and SS DNAs
were detectable in WT-transfected cells, even though the viral
DNAs were fully heat denatured (Fig. 6C, lane 1). It appeared that
the heat-denatured DNA became rapidly renatured following de-
naturation or during gel electrophoresis. Regardless of the DNA
type (DL or SS), it is important to note that the oligonucleotide
probe would detect the very end of the minus-strand DNA. South-
ern blot analysis with the oligonucleotide probe showed that the
K745A, D778A, and R781A mutants had significantly reduced lev-
els of DNA (Fig. 6C, lanes 3, 5, and 6). Intriguingly, two discrete
bands (denoted by asterisks) were detected in the WT as well as the
R781 mutant (Fig. 6C, lanes 1 and 6), in which one DNA species
migrated faster than DL DNA, and another DNA species migrated
faster than SS DNA. We speculate that these DNA species were
derived from the spliced pgRNA (25). In contrast, no band was
detected in either R703A or D777A mutant-transfected cells, in-
dicating that the minus-strand DNA synthesis was not completed
(Fig. 6C, lanes 2 and 4).
To calculate the efficiency of the minus-strand elongation step,
the level of full-length minus-strand DNA probed with 1820-F
oligomer was divided by the level of minus-strand DNA synthesis
from the 5= end, which was first normalized to the level of its
internal standard (Fig. 6D). Quantitation revealed that the K745A
mutant exhibited near-WT elongation efficiency, whereas the
D778A and R781A mutants exhibited modestly reduced elonga-
tion efficiency.
TheR781Amutanthas adefect inRNAprimer translocation.
It remains possible that the other steps of viral replication, such as
primer translocation during the plus-strand DNA synthesis, could
be affected by certain mutants. To determine a step at which these
mutants are defective, primer extension analysis with the 1744-R
primer was carried out to measure the amount of plus-strand
DNA synthesis initiated at DR2 (Fig. 6A), as previously performed
(26). As shown in Fig. 6E, the analysis showed that plus-strand
DNAs that initiated at DR2 were reduced significantly in the
R703A and D777A mutants and to a lesser extent in the R781A
mutant (Fig. 6E, lanes 2, 4, and 6), but they were only modestly
reduced in the K745A and D778A mutants (Fig. 6E, lanes 3 and 5).
Quantitation was done to examine the extent to which primer
translocation proceeds; the level of plus-strand DNA synthesis
initiated at DR2 was divided by the level of full-length, minus-
strand DNA (Fig. 6F). The data showed that the K745A and
D778A mutants did not have a defect in primer translocation.
Taken together, our results indicate that the reductions in viral
replication levels in the K745A and the D778A mutants are largely
attributable to a defect in the minus-strand synthesis (i.e., minus-
strand initiation and elongation). Intriguingly, the R781A mutant
had a significant decrease in primer translocation. Thus, our re-
sults indicate that the R781A mutant has a defect in at least three
different steps of viral genome replication: (i) minus-strand initi-
ation, (ii) minus-strand elongation, and (iii) RNA primer trans-
location during plus-strand DNA synthesis.
To exclude the possibility that steps following primer translo-
cation could be impaired by certain mutations, we also performed
primer extension analysis using 1952-R primers, which can mea-
sure the amount of elongating plus-strand DNA that had under-
gone the third template switch (Fig. 6A and data not shown). The
level of plus-strand DNA that continued to the circularization step
divided by the level of plus-strand DNA that initiated synthesis
from DR2 was then calculated. It was found that three mutants
(K745A, D778A, and R781A mutants) that we considered display
no defect in circularization (data not shown). Collectively, the
R703A, D777A, and R781A mutants exhibited a phenotype that is
consistent with a defect in RNA primer translocation or a prior
step.
FIG 5 None of the charged residues are indispensable for RNA encapsidation.
Cells were cotransfected with an HBV P-null replicon construct along with
WT Pol or an individual single-substitution mutant as indicated. RNA from
core particles (C) and total cytoplasmic fractions (T) was extracted and ana-
lyzed by RPA, as described in Materials and Methods. The protected fragment
of pgRNA is indicated with a closed arrowhead, while the riboprobe is indi-
cated with an open arrowhead. Yeast RNA served as a negative control. The
encapsidation efficiency was estimated by comparing the amount of pgRNA
detected in the C fraction to that detected in the T fraction (mean  SD).
Representative data from at least five independent experiments are shown.
Ko et al.
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Three mutants have a defect in RNase H activity. As men-
tioned above, a few bands migrating faster than DL or SS DNA
were detectable in R703A and D777A mutant- transfected cells
(Fig. 4A, lanes 2 and 6). Several discrete viral nucleic acid species
detected by the catalytic triad mutants of the RNase H domain of
HBV or DHBV were found to be RNA-DNA duplexes resulting
from a loss of RNase H activity (12). Hence, it is not unreasonable
to speculate that our three mutants (R703A, D777A, and R781A
mutants) could have similarly lost their catalytic activity. To de-
termine whether the RNase H activities of the three mutants were
lost, the viral DNA replication intermediates extracted from trans-
fected cells were treated with Escherichia coli RNase H before gel
electrophoresis, as performed previously (27). This experiment is
based upon the premise that the migration of viral RNA-DNA
hybrid molecules would shift upon exogenous RNase H treat-
ment, as the residual RNA is removed. As expected, the migration
FIG 6 Determination of defective steps in viral genome replication. (A) Diagram showing the oligonucleotide primer-binding sites. The name of each primer
refers to the position of the first nucleotide. The letter F indicates that the primer has the same polarity as the plus-strand DNA, while the letter R indicates that
the primer has the same polarity as the minus-strand DNA. (B and E) Primer extension analysis was performed to measure the amount of minus-strand DNA
synthesis extended from DR1 with the 1665-F primer (B) and the amount of plus-strand DNA synthesis initiated from DR2 with the 1744-R primer (E). To
normalize amplification efficiency between different samples, internal standard (I.S.) DNAs, which have the same primer-binding sites to each primer, were
added to each DNA sample prior to the primer extension reaction. Replication intermediate (R.I.) bands are indicated by a closed arrowhead, while I.S. bands are
indicated by an open arrowhead. A sequencing ladder is shown along with DR1 sequence, where the four nucleotides to which the nascent DNA anneals are
highlighted in bold (B). A sequencing ladder is shown along with DR2 sequence (E). Representative data from five independent experiments are shown. (C)
Southern blot analysis with heat-denatured DNA was performed to measure the amount of full-length minus-strand DNA. DNA samples were heat denatured
before electrophoresis. The 1820-F primer was 5= end labeled and used as a probe. Labeled bands comparable in size to DL DNA species are denoted as “A,”
whereas those comparable to SS DNA species are denoted as “B.” The intensities of both A and B bands were combined to measure the level of full-length
minus-strand DNA. Representative data from five independent experiments are shown. Two restriction fragments (3.2 kb and 2.2 kb) serve as size markers (open
arrowhead). Bands denoted by asterisks likely represent spliced forms of DNA derived from spliced pgRNAs. (D and F) Histograms showing the efficiency of
reverse transcription steps: minus-strand elongation (D) and primer translocation (F). The efficiency of each reverse transcription step was determined as
described previously (21). Briefly, the efficiency of minus-strand elongation was calculated as the amount of full-length minus-strand DNA divided by the
amount of minus-strand DNA synthesis extended from DR1 (D). Likewise, the efficiency of primer translocation was calculated as the level of plus-strand DNA
initiated from DR2 divided by the level of full-length minus-strand DNA (F). Error bars and values above the error bars represent standard deviations and mean
values, respectively. Statistical significance was determined using the Student t test. Differences were considered to be significant if the P value was0.05. *, P
0.05; **, P 0.001. N/A, not applicable.
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pattern of the characteristic fast-migrating bands of the three triad
mutants (D689A, E718A, and D737A mutants) was changed upon
exogenous RNase H treatment (Fig. 7, lanes 3 to 8). Likewise, in
the R703A and D777A mutants, the migration pattern of the char-
acteristic fast-migrating bands was changed in parallel (Fig. 7,
lanes 9 to 12) Further, the observation that the migration patterns
of the hybrid molecules of these mutants were indistinguishable
from those of the catalytic triad mutants led us to speculate that
these charged residues contribute to catalysis of the RNase H,
either by constituting the catalytic residues or by being involved in
metal ion coordination (27).
In contrast, unlike the R703A and D777A mutants, the R781A
mutant led to a rather abundant accumulation of DL and SS DNA
but a lack of RC DNA synthesis (Fig. 4A, lane 8, and Fig. 7, lane
13). Nonetheless, upon exogenous RNase H treatment, the shift of
DL and SS DNAs was also observed, implicating the presence of
residual RNA in two DNA species. Importantly, no such shift was
observed in the WT, as well as the K745A and D778A mutants
(Fig. 7, lane 2; data not shown). It is also notable that the DL and
SS DNAs in the R781A mutant migrated a bit slower than those of
the WT, consistent with the presence of residual RNA (Fig. 7, lane
1 versus 13). The residual RNA that caused the shift upon exoge-
nous RNase H treatment is attributable to the reduced catalytic
activity of the RNase H derived from the R781A mutant. Overall,
we conclude that the catalytic activities of the RNase H domain
were affected in all three mutants but in subtle, distinct ways: in
the R703A and D777A mutants, DNA synthesis is coupled to
RNase H activity, whereas in the R781A mutant, DNA synthesis is
uncoupled from RNase H activity (see Fig. 8).
DISCUSSION
Unlike for related retroviruses, the precise role of the RNase H
domain of hepadnaviral Pol during viral reverse transcription re-
mains largely unexplored. Our results showed that of the 16 resi-
dues we altered, three charged residues (R703, D777, and R781) in
the RNase H domain of HBV Pol are important for viral reverse
transcription; mutants with changes at the former two were defec-
tive in minus-strand synthesis, while the latter was defective in
both minus-strand synthesis and plus-strand DNA (i.e., RC DNA)
synthesis. The results imply that the catalytic activity of the RNase
H plays roles not only in removal of the RNA template but also in
a subsequent step leading to RC DNA synthesis (perhaps by gen-
erating the RNA primer needed for the RC DNA synthesis).
Based on the defects in synthesis of viral DNA replication in-
termediates, the three mutants could be classified into two groups.
The first group (R703A and D777A mutants) failed to accumulate
viral DNA replication intermediates but resulted in a few fast-
migrating species on a Southern blot (Fig. 4A, lanes 2 and 6). The
failure by the R703A and D777A mutants to complete minus-
strand DNA synthesis suggests that minus-strand DNA synthesis
was halted during elongation (Fig. 8A). Moreover, the observation
that a few bands migrating faster than DL or SS DNA were de-
tected in R703A and D777A mutant-transfected cells (Fig. 4A,
lanes 2 and 6), mirroring those detected in the putative catalytic-
site mutants (Fig. 3C), led us to speculate that the R703A and
D777A mutants are catalytically inactive. An earlier report on the
DED (catalytic triad) mutants of DHBV showed that these viral
DNA species are, in fact, hybrid molecules of RNA and minus-
strand DNA resulting from incomplete synthesis of the minus-
strand DNA (12). Indeed, the sensitivity to an exogenous RNase H
treatment (Fig. 7, lanes 10 and 12) led us to conclude that R703A
and D777A mutants have a defect in completion of minus-strand
DNA synthesis due to loss of RNase H activity. It is notable that the
mutant phenotype of these two residues (R703 and D777) is in-
distinguishable from that of the catalytic-site mutants. The impli-
FIG 7 Three single mutants have a defect in RNase H activity. Cells were cotransfected with an HBV P-null replicon construct along with WT Pol or an
individual single substitution mutant as indicated. Approximately 1/10 (WT) or 3/10 (each mutant) of the capsid-associated DNA isolated from a 60-mm
plate was analyzed by Southern blotting. DNA samples were either left untreated or subjected to E. coli RNase H treatment at 37°C for 20 min. Longer
RNase H treatment and higher RNase H concentrations had no effect on migration. After treatment, each sample was immediately separated on a 1.2%
agarose gel (14 by 12 cm). Asterisks to the right of labeled bands indicate newly appearing DNA forms following exogenous RNase H treatment. The
intensities of bands (*) shifted upon the RNase H treatment were reduced to 90% (D689A), 93% (E718A), 92% (D737A), 95% (R703A), 93% (D777A),
and 90% (R781A). Size markers (0.7 kb to 3.2 kb) were generated by restriction enzyme digestion of full-length HBV genome (open arrowhead). The
results shown in lanes 15 and 16 are short exposures of lanes 13 and 14.
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cation is that these two residues (R703 and D777) may play a
critical role in the catalytic process, similar to the DED residues.
Relevantly, while the manuscript for this article was being pre-
pared, Tavis and coworkers reported that the D777 residue is es-
sential for the RNase H activity (27). Overall, it was speculated that
the “DEDD” motif, rather than the DED motif, constitutes the
active site of the HBV RNase H, as the case of HIV RNase H,
although sequence similarity at the amino acid level is only modest
(27).
In contrast, the R781A mutant first appeared to lead to normal
accumulation of DL and SS DNAs but failed to synthesize RC
DNA (Fig. 4, lane 8). For instance, the analysis to detect the very
end of the minus-strand DNA showed that minus-strand DNA
synthesis was nearly completed to some extent in the R781A mu-
tant (Fig. 6C, lane 6, and D). To our surprise, however, two DNA
species that comigrated with the DL and SS DNAs were signifi-
cantly shifted upon exogenous RNase H treatment (Fig. 7, lanes 13
and 14), a finding that suggests the existence of some residual
RNA. Presumably, this residual RNA was significantly larger than
the short RNA primer, as no such shift was observed in the WT
(Fig. 7, lane 2). The detection of a decent amount of residual RNA
in viral DNA replication intermediates in the R781A mutant is not
necessarily inconsistent with the interpretation that the minus-
strand DNA was nearly completed. One possibility is that HBV
Pol of the R781A mutant proceeds to synthesize the minus-strand
DNA to the very end of the RNA template without complete re-
moval of the RNA template (Fig. 8B). Specifically, this mutant
RNase H with altered cleavage specificity may generate RNA
primers with different lengths, leading to predominant in situ
priming for DL DNA synthesis. This phenomenon implies that
the RT and RNase H activities could be uncoupled under certain
circumstances (12). Overall, the R781A mutant was defective in
three steps during viral reverse transcription: (i) the initiation in
minus-strand DNA synthesis (49% of the level of the WT), (ii) the
elongation of minus-strand DNA synthesis (38% of the level of the
WT), and (iii) the RNA primer translocation during plus-strand
RC DNA synthesis (47% of the level of the WT).
In addition to above-mentioned three mutants (R703A,
D777A, and R781A mutants), which were severely defective in RC
DNA synthesis, it was notable that RC DNA synthesis was re-
duced, to a lesser extent, in K745A and D778A mutants (Fig. 4A,
lanes 5 and 7). Inconsistent with an expectation from the reduced
RC DNA, the data showed that the primer translocation for the
RC DNA synthesis appeared not to be defective (Fig. 6F). Thus, a
question is which step of viral reverse transcription is defective. In
fact, our data indicated that the K745A and D778A mutants were
modestly defective in the initiation of minus-strand DNA synthe-
sis (Fig. 6B, lanes 3 and 5) and appeared to be somewhat defective
in minus-strand elongation (Fig. 6D), although the reduction in
the K745A mutant was not statistically significant. Overall, the
reduction of the RC DNA in the K745A and D778A mutants is
almost fully accounted for by the defects seen in minus-strand
DNA synthesis. Nonetheless, the aforementioned conclusion can-
not account for abundant accumulation of the DL DNA in the
K745A mutant (Fig. 4A, lane 5). It could be due to the overesti-
mation of the primer translocation efficiency shown in Fig. 6F, in
which the value obtained from the primer extension analysis (Fig.
6E) was divided by the amount of the full-length minus-strand
DNA shown in Fig. 6C. The latter could be underestimated as a
consequence of using only one short-length probe (i.e., 1820-F;
17-mer). Therefore, it remains possible that the K745A mutant is
indeed defective in RNA primer translocation during plus-strand
RC DNA synthesis.
Overall, we found that five charged residues are essential for
FIG 8 Diagram of hypothetical RNA-DNA hybrid molecules generated by three single-substitution mutants. (A) Two mutants (R703A and D777A mutants)
failed to synthesize full-length minus-strand DNA. As a result, hybrid molecules consisting of short-length minus-strand DNAs and undigested viral RNA
fragments are detected. These two mutants manifested a phenotype that is indistinguishable from those of catalytic triad mutants (D689A, E718A, and D737A
mutants). Our interpretation is that the RT activity is coupled to the RNase H activity in these mutants. (B) In contrast to the mutants in panel A, the full-length
minus-strand DNA is synthesized in the R781A mutant. Hybrid molecules consisting of the full-length minus-strand DNA and some undigested residual viral
RNAs may be generated. Moreover, the plus-strand DNA synthesis (i.e., in situ priming) proceeds to some extent. Our interpretation is that the RT activity is
uncoupled to the RNase H activity in the R781A mutant.
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the efficient accumulation of RC DNA synthesis. Three single
point mutants harboring an alanine substitution at R703, D777,
and R781 were severely defective in RC DNA synthesis, while the
remaining two single point mutants harboring an alanine substi-
tution at K745 and D778 were modestly defective in RC DNA
synthesis. An interpretation is that the former three residues are
involved in the catalysis of RNase H activity, as evidenced by the
presence of residual RNA in the DNA replication intermediates,
while the latter two residues are not directly involved in the catal-
ysis, as evidenced by the lack of residual RNA in the DNA replica-
tion intermediates (Fig. 7 and data not shown). Nonetheless, we
cannot exclude the possibility that the defects were, to some ex-
tent, attributable to misfolding caused by substitution mutations.
Whether or not the RNase H domain contributes to encapsi-
dation remains unclear. Earlier work reported that HBV Pol har-
boring a C-terminal truncation of the RNase H domain failed to
package pgRNA, suggesting a role for the RNase H domain in
encapsidation (28). Subsequently, a natural variant of DHBV en-
coding C711Y substitution in the RNase H domain was shown to
be defective in RNA encapsidation (10, 12). It should be noted that
all substitution mutants examined in these earlier studies involved
a drastic amino acid alteration, e.g., C711Y (11). Thus, a defect of
the mutants could simply be attributable to the particular amino
acid chosen as the replacement. Furthermore, only limited genetic
analysis of the HBV counterpart has been performed (11). In con-
trast, our data showed that none of the charged residues we exam-
ined are important for RNA encapsidation. Nonetheless, it re-
mained possible that other charged residues could be essential for
encapsidation. To address this issue, in addition to the aforemen-
tioned charged residues, eight other charged residues (R680A,
R762A, R788A, R792A, R796A, R801A, D807A, and R830A), of
which seven were arginine residues, were analyzed in parallel. The
data showed that none of these charged residues are essential for
viral genome replication or encapsidation (data not shown).
Hence, it appeared that none of the charged residues encoded in
the RNase H domain are essential for viral RNA encapsidation.
Current treatments for chronic hepatitis B largely rely on nu-
cleoside analogs (NUCs) such as lamivudine, adefovir, entecavir,
and tenofovir (29). Although viral suppression is achieved in up to
95% of patients treated with NUCs, hepatitis B surface antigen
(HBsAg) loss, which is a major treatment endpoint that allows for
treatment cessation, is achieved in less than 10% of patients after 5
years of NUC administration. It is expected that addition of one or
more drugs with a novel target to the current regimen should
markedly improve the response to therapy (30). In this regard, the
RNase H activity of HBV Pol represents an attractive target for
anti-HBV therapy (27, 31).
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